Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults

NCT03766724 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes

Interventions

DRUG: Evogliptin→Evogliptin+Empagliflozin→Empagliflozin
DRUG: Empagliflozin→Evogliptin→Evogliptin+Empagliflozin
DRUG: Evogliptin→Evogliptin+Dapagliflozin→Dapagliflozin
DRUG: Dapagliflozin→Evogliptin→Evogliptin+Dapagliflozin

Sponsor

Dong-A ST Co., Ltd.